MEDICAID: Provides relative to unauthorized fees charged by healthcare providers for certain treatments
Summary
HB 760 creates a new statute in the Medicaid laws to address unauthorized fees and co-payments charged by healthcare providers for services tied to medication-assisted treatment. Under the bill, a provider enrolled in Louisiana’s medical assistance programs who has accepted a Medicaid recipient as a patient must accept the Medicaid payment as payment in full for any covered service where a prescription is issued for medication-assisted treatment. The bill also bars providers from charging any additional fee or co-payment for those covered services unless the Louisiana Department of Health has expressly authorized it.
The bill further establishes a penalty for violations: a provider who charges unauthorized fees or co-payments may be terminated or excluded from participation in the medical assistance programs for up to one year, as determined by the Department of Health. In effect, the measure adds a specific enforcement mechanism to existing Medicaid participation rules and is aimed at preventing patients from being billed beyond what Medicaid covers for this category of treatment.
Impact
HB 760 would add R.S. 46:440.3 to Louisiana law and directly regulate billing practices for Medicaid-enrolled healthcare providers offering medication-assisted treatment-related covered services. It would limit providers’ ability to collect any payment beyond Medicaid reimbursement unless the Department of Health authorizes the charge, and it would give LDH discretion to impose program termination or exclusion for violations. The bill primarily affects Medicaid providers, Medicaid recipients, and the Department of Health’s oversight and enforcement authority.
Sentiment
Based on the bill text and available context, the measure appears to be framed as a consumer-protection and Medicaid-integrity bill, with no recorded committee debate or votes yet. The overall sentiment is likely supportive in intent, since the bill seeks to prevent surprise or unauthorized charges to vulnerable Medicaid patients receiving medication-assisted treatment. Because there are no transcripts or vote records, there is no evidence of formal opposition or amendment activity in the available materials.
Contention
The main potential point of contention is the scope of the billing restriction and enforcement penalty. Providers may view the bill as limiting flexibility to collect fees they believe are permissible or necessary, while supporters are likely to argue that Medicaid recipients should not be charged extra for covered services tied to medication-assisted treatment. Another possible issue is the discretion given to the Louisiana Department of Health to determine violations and impose exclusion or termination for up to one year, which could raise concerns about administrative enforcement and due process.